UNIFORM CONTROLLED SUBSTANCES – Amends existing law to classify mifepristone and misoprostol as schedule IV drugs.

Idaho's H 137 amends state law to classify mifepristone and misoprostol as Schedule IV controlled substances under the Uniform Controlled Substances Act. This change directly affects healthcare providers, pharmacies, and patients in Idaho who currently access these medications, which are used for medical abortion and other reproductive health treatments. The bill adds the drugs explicitly to Schedule IV, which regulates substances with lower abuse potential but still requiring medical oversight. The law will take effect on July 1, 2025, requiring compliance with Schedule IV prescribing and dispensing rules.